treatment of qooba (tinea cruris) with unani formulations
Phase 2
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2020/03/023861
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically and microscopically diagnosed patient of Tinea cruris
Patient of either gender
Age group 20-50 years
Patient who have agreed to sign the informed consent form
Exclusion Criteria
Patient below 20 years and above 50 years of age
Pregnant and lactating women
Patient with severe systemic and metabolic disorders
Diabetic, HIV/AIDS or other immunocompromised patients
Patient with concomitant skin disease like eczema and psoriasis
Patient who are taking conventional medicine for Tinea cruris will be enrolled for the trial after a washed out period of 15 days
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method